EFFICACY OF LOW-DOSE CYTARABINE-BASED REGIMEN(CAG) FOLLOWED BY AZACITIDINE FOR ELDERLY PATIENTS WITH MDS/AML

被引：0
|
作者：
Tabayashi, Takayuki [1 ]
Takahashi, Yasuyuki [1 ]
Kimura, Yuta [1 ]
Tomikawa, Tatsuki [1 ]
Sagawa, Morihiko [1 ]
Anan, Tomoe [1 ]
Watanabe, Reiko [1 ]
Tokuhira, Michihide [1 ]
Mori, Shigehisa [1 ]
Kizaki, Masahiro [1 ]
机构：
[1] Saitama Med Univ, Saitama Med Ctr, Dept Hematol, Saitama, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-21-1
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of CHG regimen (low-dose cytarabine, homoharringtonine with G-CSF priming) as induction chemotherapy for elderly patients with high-risk MDS or AML transformed from MDS
    Lingyun Wu
    Xiao Li
    Jiying Su
    Qi He
    Xi Zhang
    Chunkang Chang
    Quan Pu
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1563 - 1569
  • [2] Efficacy and safety of CHG regimen (low-dose cytarabine, homoharringtonine with G-CSF priming) as induction chemotherapy for elderly patients with high-risk MDS or AML transformed from MDS
    Wu, Lingyun
    Li, Xiao
    Su, Jiying
    He, Qi
    Zhang, Xi
    Chang, Chunkang
    Pu, Quan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (10) : 1563 - 1569
  • [3] Azacitidine (AZA) Combination Therapy with Low-Dose AraC for Aggressive Type MDS, Overt AML, and AML Patients
    Hirai, Manabu
    Inoue, Atsushi
    Hashimura, Mitsuharu
    Aimoto, Mizuki
    Sakamoto, Erina
    BLOOD, 2015, 126 (23)
  • [4] Cladribine and Low-Dose Cytarabine-Based Salvage Therapy for Relapsed/Refractory AML in a Predominantly Venetoclax-Exposed Cohort
    Cheung, Edna
    Schumann, Claire
    Zhang, Tian Y.
    Fakhri, Bita
    Gotlib, Jason
    Liedtke, Michaela
    Shomali, William
    Mannis, Gabriel
    BLOOD, 2023, 142
  • [5] LOW-DOSE CYTARABINE AFTER FAILURE OF 5-AZACITIDINE AS PALLIATIVE TREATMENT FOR ELDERLY PATIENTS WITH AML OR HIGH-RISK MDS INELIGIBLE FOR INTENSIVE CHEMOTHERAPY. A RETROSPECTIVE SINGLE CENTER ANALYSIS
    Jakob, C.
    Peinert, S.
    Breywisch, F.
    Guenther, B.
    Dittberner, K.
    Boger, L.
    Rothmann, F.
    Maschmeyer, G.
    HAEMATOLOGICA, 2015, 100 : 386 - 386
  • [6] INFECTION OF ELDERLY PATIENTS RECEIVING HIGH-DOSE CYTARABINE-BASED CHEMOTHERAPY FOR INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML)
    NEMUNAITIS, J
    MEYER, W
    NEMUNAITIS, J
    TAYLOR, E
    RILEY, C
    COOPER, B
    LEUKEMIA RESEARCH, 1994, 18 (08) : 649 - 650
  • [7] Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia
    Qian, S.
    Li, J.
    Zhang, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia
    Qian, Si-Xuan
    Li, Jian-Yong
    Tian, Tian
    Shen, Yun-Feng
    Jiang, Yuan-Qiang
    Lu, Hua
    Wu, Han-Xin
    Zhang, Su-Iiang
    Xu, Wei
    LEUKEMIA RESEARCH, 2007, 31 (10) : 1383 - 1388
  • [9] Long-term results of an ultra low-dose cytarabine-based regimen for the treatment of acute megakaryoblastic leukaemia in children with Down syndrome
    Al-Ahmari, Ali
    Shah, Niketa
    Sung, Lillian
    Zipursky, Alvin
    Hitzler, Johann
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 (06) : 646 - 648
  • [10] The efficacy and toxicity of the CHG priming regimen (low-dose cytarabine, homoharringtonine, and G-CSF) in higher risk MDS patients relapsed or refractory to decitabine
    Xiu, Cai
    Li, Xiao
    Wu, Lingyun
    Xu, Feng
    He, Qi
    Zhang, Zheng
    Wu, Dong
    Song, Luxi
    Su, Jiying
    Zhou, Liyu
    Zhao, Youshan
    Tao, Ying
    Chang, Chunkang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (12) : 3089 - 3097
12345